Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors | Zendy

Marco A. Purbhoo | Zendy; Deborah H. Sutton | Zendy; Joanna E. Brewer | Zendy; Rebecca E. Mullings | Zendy; Maxine E. Hill | Zendy; Tara Mahon | Zendy; Julia Karbach | Zendy; Elke Jäger | Zendy; Brian Cameron | Zendy; Nikolai M. Lissin | Zendy; Paresh Vyas | Zendy; JiLi Chen | Zendy; Vincenzo Cerundolo | Zendy; Bent K. Jakobsen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors

Author(s) -

Marco A. Purbhoo,

Deborah H. Sutton,

Joanna E. Brewer,

Rebecca E. Mullings,

Maxine E. Hill,

Tara Mahon,

Julia Karbach,

Elke Jäger,

Brian Cameron,

Nikolai M. Lissin,

Paresh Vyas,

JiLi Chen,

Vincenzo Cerundolo,

Bent K. Jakobsen

Publication year - 2006

Publication title -

the journal of immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.737

H-Index - 372

eISSN - 1550-6606

pISSN - 0022-1767

DOI - 10.4049/jimmunol.176.12.7308

Subject(s) - epitope , context (archaeology) , t cell receptor , human leukocyte antigen , antigen presentation , biology , receptor , antigen , t cell , microbiology and biotechnology , chemistry , immune system , immunology , biochemistry , paleontology

Presentation of intracellular tumor-associated Ags (TAAs) in the context of HLA class I molecules offers unique cancer-specific cell surface markers for the identification and targeting of tumor cells. For most peptide Ags, the levels of and variations in cell surface presentation remain unknown, yet these parameters are of crucial importance when considering specific TAAs as targets for anticancer therapy. Here we use a soluble TCR with picomolar affinity for the HLA-A2-restricted 157-165 epitope of the NY-ESO-1 and LAGE-1 TAAs to investigate presentation of this immunodominant epitope on the surface of a variety of cancer cells. By single molecule fluorescence microscopy, we directly visualize HLA-peptide presentation for the first time, demonstrating that NY-ESO-1/LAGE-1-positive tumor cells present 10-50 NY-ESO-1/LAGE-1(157-165) epitopes per cell.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research